Shenzhen Bioeasy Biotechnology Co. Ltd. Cash Flow Quality Index
Shenzhen Bioeasy Biotechnology Co. Ltd. cash flow quality index. Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Cash Flow Quality Index of 0.58x as of September 2025. Operating cash flow of CN¥9.12 Million is below net income of CN¥15.68 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Shenzhen Bioeasy Biotechnology Co. Ltd. cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
Cash flow quality index of Shenzhen Bioeasy Biotechnology Co. Ltd. from 2016 to 2025. Historical Cash Flow Quality Index for Shenzhen Bioeasy Biotechnology Co. Ltd. across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. See 300942 net asset quality score to measure how much of total assets are equity-financed.
Shenzhen Bioeasy Biotechnology Co. Ltd. Cash Flow Quality Index by Year (2016–2025)
Shenzhen Bioeasy Biotechnology Co. Ltd. cash flow quality index by year from 2016 to 2025. Year-by-year earnings quality comparison for Shenzhen Bioeasy Biotechnology Co. Ltd.. For the full cash flow conversion analysis, see 300942 cash flow metrics.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 4.87x | CN¥66.87 Million | CN¥13.74 Million | ▲ +136.0% |
| 2024 | 2.06x | CN¥34.26 Million | CN¥16.62 Million | ▲ +11.7% |
| 2022 | 1.85x | CN¥152.55 Million | CN¥82.66 Million | ▲ +70.9% |
| 2021 | 1.08x | CN¥255.42 Million | CN¥236.47 Million | ▲ +10.8% |
| 2020 | 0.97x | CN¥63.79 Million | CN¥65.45 Million | ▲ +33.8% |
| 2019 | 0.73x | CN¥67.24 Million | CN¥92.29 Million | ▼ -7.0% |
| 2018 | 0.78x | CN¥57.93 Million | CN¥73.91 Million | ▲ +30.4% |
| 2017 | 0.60x | CN¥23.60 Million | CN¥39.27 Million | ▼ -61.2% |
| 2016 | 1.55x | CN¥36.31 Million | CN¥23.42 Million | — |